2 Jun 2026Open access
Revisiting BACE-1: How Machine Learning and Molecular Dynamics Unveiled Potential Anti-Alzheimer’s Activity of a Cysteinyl Sulfoxide DerivativePublisher siteBiophysica, Alzheimer's disease research and treatments
UniversitiesSalerwe Mosebi
Active, last published 2026
In hiv/aids drug development and treatment
Salerwe
Mosebi
Scholar“Research focused on HIV/AIDS drug development and treatment and adjacent fields.”
University of South Africa
Claim Your Profile12
H-index
400
Citations
Salerwe has not officially claimed their profile. If you are Salerwe, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
alerwe Mosebi is a researcher working on HIV/AIDS drug development and treatment. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Salerwe's work has been cited 400 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
HIV/AIDS drug development and treatment×14HIV Research and Treatment×12Computational Drug Discovery Methods×6Biochemical and Molecular Research×5Malaria Research and Control×3
04 · Where I am
Affiliations
Affiliation on published researchUniversity of South AfricaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
9 works17 Apr 2026Open access
Mal-Predict: Machine learning-guided rapid virtual screening of compounds against selected targets of Plasmodium falciparum validated using molecular dynamics simulationPublisher siteResearch Square, Computational Drug Discovery Methods
9 Mar 2026Open access
Emphasizing the structural and computational characterisation of an HIV-1 IN binding interface against potential inhibitors for a promising drug strategyPublisher siteResearch Square, HIV/AIDS drug development and treatment
4 Feb 20261cites
Harunganol-B and beyond: unveiling nature’s arsenal against drug-resistant Acinetobacter baumanniiPublisher siteIn Silico Pharmacology, Andrographolide Research and Applications
1 Nov 2024Open access3cites
Oleanolic acid purified from the stem bark of <i>Olax subscorpioidea</i> Oliv. inhibits the function and catalysis of human 17 <i>β</i> -hydroxysteroid dehydrogenase 1Publisher siteJournal of Biomolecular Structure and Dynamics, Natural product bioactivities and synthesis
28 Oct 2024Open access
Human cellular restriction factors that target SARS-CoV-2 replicationPublisher siteFrontiers in Virology, SARS-CoV-2 and COVID-19 Research
17 Oct 2024Open access1cites
Susceptibility of HPV-18 Cancer Cells to HIV Protease InhibitorsPublisher siteViruses, Hepatitis B Virus Studies
6 Aug 2024Open access6cites
The characteristic structural and functional dynamics of P. falciparum DHFR binding with pyrimidine chemotypes implicate malaria therapy designPublisher siteChemical Physics Impact, HIV/AIDS drug development and treatment
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Salerwe?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you